Longitudinal Antimalarial Combinations in Uganda

PHASE3CompletedINTERVENTIONAL
Enrollment

601

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

June 30, 2006

Study Completion Date

December 31, 2008

Conditions
Malaria
Interventions
DRUG

Amodiaquine+Artesunate

Amodiaquine 10 mg/kg on day 1, then 5 mg/kg on day 2 and 3; Artesunate 4 mg/kg/d for three days

DRUG

Amodiaquine+Sulfadoxine/Pyrimethamine

Amodiaquine 10 mg/kg on day 1, then 5 mg/kg on day 2 and 3; S/P at 25 mg/kg sulfadoxine and 1.25 mg/kg pyrimethamine single dose

DRUG

Artemether+Lumefantrine

Artemether 20 mg + Lumefantrine 120 mg 6 dose regimen at 0 and 8 hours on day 1 and twice daily on days 2 and 3:5 kg to \< 15 kg: 1 tab/dose; 15 to 24 kg: 2 tabs/dose; \>35 kg:4 tabs per dose

Trial Locations (1)

Unknown

Assessment Center - Mulago Hospital, Kampala

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of California, San Francisco

OTHER

NCT00123552 - Longitudinal Antimalarial Combinations in Uganda | Biotech Hunter | Biotech Hunter